Sunshine Biopharma Inc. (SBFM)
SBFM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2363
-21.75% on the day
Market cap
$3.6M
Nano cap
Revenue · 2025
$36.3M
+4.1% on 2024
Net income · 2025
-$6.0M
-16.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SBFM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001402328 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | CO |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $36.3M |
| Net income | -$6.0M |
| Operating income | -$6.2M |
| Net margin | -16.5% |
| Operating margin | -17.2% |
| Revenue growth | +4.1% |
| Cash | Not in SEC XBRL data |
| Total assets | $30.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2026-10-09 |
| Latest annual report FORM 10-K FOR DEC 2025 | 10-K | 2026-04-03 |
| Latest quarterly / interim FORM 10-Q FOR JUN 2026 | 10-Q | 2026-08-13 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-14 |
| Latest proxy FORM DEFA 14A | DEFA14A | 2025-10-23 |
Source: SEC EDGAR submissions feed, 426 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics Inc. | $0.9970 | +14.28% | $3.6M |
| GRI | GRI Bio Inc. | $1.55 | -1.27% | $3.4M |
| EOCN | Eocene Ltd. | $3.17 | -1.71% | $3.3M |
| CAPS | Capstone Holding Corp. | $0.1242 | -6.83% | $3.3M |
| SXTP | 60 Degrees Pharmaceuticals Inc. | $0.9000 | -1.70% | $3.2M |
| CMND | Clearmind Medicine Inc. Common Shares | $6.23 | -4.74% | $3.2M |
| RDHL | Redhill Biopharma Ltd. | $0.5150 | -3.45% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier